Class 3 Medicines Recall: Norgine Limited, MOVICOL Ease Citrus Powder for oral solution 13.7 g, EL(26)A/08
UKClass 3 Medicines Recall: Norgine Limited, MOVICOL Ease Citrus Powder for oral solution 13.7 g, EL(26)A/08
Recalling Firm: Norgine Limited
Reason for Recall / Hazard
Norgine Limited is recalling one batch of product as a precautionary measure due to some units containing low amounts of active ingredients....
Product Description & Identification
Norgine Limited is recalling one batch of product as a precautionary measure due to some units containing low amounts of active ingredients.
Affected Products
Class 3 Medicines Recall: Norgine Limited, MOVICOL Ease Citrus Powder for oral solution 13.7 g, EL(26)A/08
Additional Source Details
| Field | Value |
|---|---|
| Guid | tag:www.gov.uk,2005:/drug-device-alerts/class-3-medicines-recall-norgine-limited-movicol-ease-citrus-powder-for-oral-solution-13-dot-7-g-el-26-a-slash-08 |
| Link | https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-norgine-limited-movicol-ease-citrus-powder-for-oral-solution-13-dot-7-g-el-26-a-slash-08 |
| Pub Date | 2026-02-17T10:00:42+00:00 |
| Extracted category | drugs |
Check Other Products In Your Household
Free Safety ToolsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Overview
- Recalling FirmNorgine Limited
- Risk LevelMedicines Recall
- DistributionUnited Kingdom
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Norgine Limited - Class 3 Medicines Recall: Norgine Limited, MOVICOL Ease Citrus Powder for oral solution 13.7 g, EL(26)A/08 Check if your household is affected: https://therecallfile.com/recalls/class-3-medicines-recall-norgine-limited-movicol-ease-citrus-powder-fo/UK-MHRA-class-3-medicines-recall-norgine-limited-movicol-ease-citrus-powder-for-oral-solution-13-dot-7-g-el-26-a-slash-08
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Related Recalls
UKMHRA Safety Roundup: July 2026
MHRA Safety Roundup: July 2026
Summary of the latest safety advice for medicines and medical device users...
UKClass 4 Medicines Defect Notification: Neuraxpharm UK Ltd, Tuzulby prolonged-release chewable tablets, EL(26)A/36
Class 4 Medicines Defect Notification: Neuraxpharm UK Ltd, Tuzulby prolonged-release chewable tablets, EL(26)A/36
Neuraxpharm UK Ltd has informed the MHRA of missing safety information in the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) for certain batches of Tuzulby prolonged r...
FDA DrugsNystatin Cream USP, (100,000 USP Nystatin Units), NET WT 15 g, Rx only, 15 g tube, Manufactured by Padagis, Yeruham, Israel, NDC 45802-059-35
Nystatin Cream USP, (100,000 USP Nystatin Units), NET WT 15 g, Rx only, 15 g tube, Manufactured by Padagis, Yeruham, Israel, NDC 45802-059-35
Subpotent Drug: Low out of specification assay results performed during long-term stability testing.